Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 26

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 26
---
ulkarni will continue serving as chair of the Compensation Committee until the Annual Meeting, and subject to Dr. Becker being duly elected at the Annual Meeting, at which point Dr. Kulkarni will step down and Dr. Becker will be chair of the Compensation Committee. (2) Ms. Jarrett stepped down from the Audit Committee and was appointed to the Compensation Committee and Nominating and Governance Committee, effective April 22, 2025. (3) Dr. Graham was appointed chair of the Nominating and Governance Committee, effective April 22, 2025. (4) Mr. Thiara is not standing for re-election at the Annual Meeting and will retire from the Board, the Compensation Committee and the Nominating and Governance Committee at the expiration of his current term, as of the date of the Annual Meeting. Below is a description of the Audit Committee, Compensation Committee and Nominating and Governance Committee. The written charters of the committees are available on the Governance section of our investor relations website at investors.zurabio.com. Audit Committee As of the date of this Proxy Statement, the members of our Audit Committee are Steve Schoch, Sandeep Kulkarni and Amit Munshi, with Steve Schoch serving as the chair of the Audit Committee. Each of Steve Schoch, Sandeep Kulkarni and Amit Munshi is independent under the rules and regulations of the SEC and Nasdaq listing standards applicable to Audit Committee members. The Board has determined that Steve Schoch qualifies as an audit committee financial expert within the meaning of SEC regulations and meets the financial sophistication requirements of Nasdaq. In arriving at these determinations, the Board has examined each Audit Committee member’s scope of experience and the nature of their employment. The primary purpose of the Audit Committee is to discharge the responsibilities of our Board with respect to the corporate accounting and financial reporting processes, systems of internal control and

13

TABLE OF CONTENTS financial statement audits, and to oversee the independent registered public accounting firm. Specific responsibilities of the Audit Committee include: • helping the Board oversee corporate accounting and financial reporting processes; • managing the selection, engagement, qualifications, independence and performance of a qualified firm to serve as the independent registered public accounting firm to audit the financial statements; • discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent accountants, the interim and year-end operating results; • developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters